10X Genomics Inc Cash Flow Quality Index
Latest as of June 2025:
0.51x
10X Genomics Inc cash flow quality index. 10X Genomics Inc (TXG) has a Cash Flow Quality Index of 0.51x as of June 2025. Operating cash flow of $17.71 Million is below net income of $34.54 Million, suggesting accrual-heavy earnings not yet converted to cash. See TXG FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
0.51x
Operating CF / Net Income
Operating Cash Flow
$17.71 Million
USD
Net Income
$34.54 Million
USD
Data as of
Jun 2025
Most recent filing
10X Genomics Inc Cash Flow Quality Index by Year (None–None)
10X Genomics Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for 10X Genomics Inc. For the full cash flow conversion analysis, see TXG operating cash flow.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.